Combination Trastuzumab With Expanded Natural Killer Cells for Treating HER2-positive Gastric Cancer
Clinical trial NCT02805829 · UNKNOWN
Trial details
- NCT number
- NCT02805829
- Sponsor
- Xuzhou Medical University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2020-01-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.